Clinical Scorecard: Beyond the Heel Prick

At a Glance

Key Highlights

• Scotland has added spinal muscular atrophy to its newborn screening program.
• Advances in sequencing technology enable comprehensive genomic approaches.
• Public support for genetic testing is high, with 90% of people in England willing to undergo testing.
• WGS can reduce diagnostic odyssey and improve outcomes in rare and common conditions.
• Integration of genomic data into healthcare systems is crucial for effective use.

Guideline-Based Recommendations

Diagnosis

• Implement whole genome sequencing for newborns to facilitate early diagnosis.

Management

• Adopt risk-informed screening and care pathways based on genomic data.

Monitoring & Follow-up

• Utilize genomic health records as a lifelong resource for ongoing care.

Risks

• Consider genetic variations that may affect medication efficacy and adverse reactions.

Patient & Prescribing Data

Adults receiving medications influenced by genetic variations.

Tailoring drugs and dosages to individual genomes can reduce adverse drug reactions.

Clinical Best Practices

• Generate reliable genomic health records for lifelong use.
• Build a connected data infrastructure linking genomic data with electronic health records.
• Empower individuals to access their genomic records for informed decision-making.
• Move from binary screening to disease stratification for tailored clinical decisions.

References

• NHS Genomic Screening Initiatives